Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH Antagonist in Early-onset Severe OHSS
NCT02784457Phase 2Completed
- Sponsor
- Ain Shams University
- Start
- Jun 2014
- Primary completion
- Dec 2015
- Modality
- Peptides, Small Molecules
01
Overview
A Phase 2 trial of cetrorelix in ovarian hyperstimulation syndrome (OHSS), sponsored by Ain Shams University. Started Jun 2014; status: completed.
02
Drugs
cetrorelix
03
Conditions
ovarian hyperstimulation syndrome (OHSS)
Beyond the preview
Go deeper on NCT02784457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02784457.